TY - JOUR
T1 - Endothelin B receptor-mediated protection against anoxia-reoxygenation injury in perfused rat liver
T2 - Nitric oxide-dependent and-independent mechanisms
AU - Taniai, Hisashi
AU - Suematsu, Makoto
AU - Susuki, Tsuneharu
AU - Norimizu, Shinji
AU - Hori, Rio
AU - Ishimura, Yuzuru
AU - Nimura, Yuji
N1 - Funding Information:
Abbreviations: ET, endothelin; L-NAME, Nv-nitro-L-arginine methyl ester; SNAP, S-nitroso-N-acetyl penicillamine; LDH, lactate dehydrogenase; cGMP, cyclic guanosine monophosphate; A/R, anoxia/reoxygenation; B/P, bile salt/phospholipid ratio. From the 1Department of Biochemistry, School of Medicine, Keio University, Tokyo, Japan; and 2The First Department of Surgery, Nagoya University School of Medicine, Nagoya, Japan. Received June 30, 2000; accepted January 4, 2001. Supported by grants from Tokyo Biochemical Research Foundation, from Advanced Medical Technology in Health Sciences Research Grants from Ministry of Health and Welfare in Japan, and from Keio Medical Sciences Fund. Address reprint requests to: Makoto Suematsu, M.D., Ph.D., Associate Professor, Department of Biochemistry, School of Medicine, Keio University, 35 Shinanoma-chi, Shinjuku-ku, Tokyo 160-8582, Japan. E-mail: msuem@med.keio.ac.jp; fax: 81-3-3358-8138. Copyright © 2001 by the American Association for the Study of Liver Diseases. 0270-9139/01/3304-0018$35.00/0 doi:10.1053/jhep.2001.23001
PY - 2001
Y1 - 2001
N2 - This study aimed to investigate the roles of endothelin (ET) receptors in biliary dysfunction and cell injury in post-ischemic livers. Rat livers perfused with oxygenated Krebs-Henseleit solution were exposed to reoxygenation following 20-minute hypoxia. The anoxic perfusion decreased bile output and reduced cyclic guanosine monophosphate (cGMP) contents, an index of nitric oxide (NO) generation. Upon reoxygenation, the decreased bile was not fully recovered, and the resistance increased biphasically: an early transient spike accompanied by an elevated release of ET-1 and a rise accompanied by a cGMP elevation in the later period. The initial vasoconstriction appeared to be mediated by both ETA and ETB receptors, as judged by inhibitory effects of their antagonists, BQ-485 and BQ-788, respectively, while the late elevation of the resistance was not attenuated by these reagents, but rather enhanced by the ETB blockade. The BQ-788 treatment attenuated the reoxygenation-induced cGMP elevation and induced bile acid-dependent choleresis. However, such a change upon the ETB blockade coincided with dissociation of a recovery of phospholipids and aggravation of cell injury. The BQ-788-elicited deterioration of reoxygenation-elicited changes was attenuated by NO supplement with S-nitroso-N-acetyl penicillamine. NW-Nitro-L-arginine methyl ester, an NO synthase inhibitor, mimicked biliary changes elicited by the ETB blockade but without causing notable cell injury. Under these circumstances, coadministration of clotrimazole, an inhibitor of cytochrome P450 mono-oxygenases, elicited the injury comparable with that observed under the ETB blockade. These results suggest that ETB-mediated signaling limits excessive bile acid excretion and plays a protective role against reoxygenation injury through mechanisms involving both NO-dependent and-independent processes.
AB - This study aimed to investigate the roles of endothelin (ET) receptors in biliary dysfunction and cell injury in post-ischemic livers. Rat livers perfused with oxygenated Krebs-Henseleit solution were exposed to reoxygenation following 20-minute hypoxia. The anoxic perfusion decreased bile output and reduced cyclic guanosine monophosphate (cGMP) contents, an index of nitric oxide (NO) generation. Upon reoxygenation, the decreased bile was not fully recovered, and the resistance increased biphasically: an early transient spike accompanied by an elevated release of ET-1 and a rise accompanied by a cGMP elevation in the later period. The initial vasoconstriction appeared to be mediated by both ETA and ETB receptors, as judged by inhibitory effects of their antagonists, BQ-485 and BQ-788, respectively, while the late elevation of the resistance was not attenuated by these reagents, but rather enhanced by the ETB blockade. The BQ-788 treatment attenuated the reoxygenation-induced cGMP elevation and induced bile acid-dependent choleresis. However, such a change upon the ETB blockade coincided with dissociation of a recovery of phospholipids and aggravation of cell injury. The BQ-788-elicited deterioration of reoxygenation-elicited changes was attenuated by NO supplement with S-nitroso-N-acetyl penicillamine. NW-Nitro-L-arginine methyl ester, an NO synthase inhibitor, mimicked biliary changes elicited by the ETB blockade but without causing notable cell injury. Under these circumstances, coadministration of clotrimazole, an inhibitor of cytochrome P450 mono-oxygenases, elicited the injury comparable with that observed under the ETB blockade. These results suggest that ETB-mediated signaling limits excessive bile acid excretion and plays a protective role against reoxygenation injury through mechanisms involving both NO-dependent and-independent processes.
UR - http://www.scopus.com/inward/record.url?scp=0035086401&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0035086401&partnerID=8YFLogxK
U2 - 10.1053/jhep.2001.23001
DO - 10.1053/jhep.2001.23001
M3 - Article
C2 - 11283854
AN - SCOPUS:0035086401
SN - 0270-9139
VL - 33
SP - 894
EP - 901
JO - Hepatology
JF - Hepatology
IS - 4
ER -